Showing results (231-240 of 296) with videos related to
Sort By:
Pageof 30
Frontiers in Oncology|January 28, 2022
Cost and Toxicity Comparisons of Two IMRT Techniques for Prostate Cancer: A Micro-Costing Study and Weighted Propensity Score Analysis Based on a Prospective StudyIngrid Masson, Martine Bellanger, Geneviève Perrocheau, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 3, 2013
STROGAR - STrengthening the Reporting Of Genetic Association studies in RadiogenomicsSarah L Kerns, Dirk de Ruysscher, Christian N Andreassen, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 14, 2026
Radiotherapy with twice weekly Gemcitabine and Cisplatin compared to Cisplatin alone for organ preservation in muscle-invasive bladder cancer: results of the GETUG V04 randomized phase II trialMorgan Michalet, Philippe Ronchin, Thomas Reynaud, et al.BMC Cancer|April 18, 2015
Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in FranceNadine Houédé, Philippe Beuzeboc, Sophie Gourgou, et al.Oncotarget|September 13, 2014
HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical modelsGaëlle Thomas, Thierry Chardès, Nadège Gaborit, et al.Substance Use & Misuse|August 8, 2013
Feasibility and Efficacy of an Addiction Treatment Program in Patients With Upper Aerodigestive Tract CancerPascal Perney, Yohan Duny, Bertrand Nalpas, et al.The Lancet. Oncology|October 1, 2020
Adjuvant radiotherapy versus early salvage radiotherapy plus short-term androgen deprivation therapy in men with localised prostate cancer after radical prostatectomy (GETUG-AFU 17): a randomised, phase 3 trialPaul Sargos, Sylvie Chabaud, Igor Latorzeff, et al.Clinical and Translational Radiation Oncology|July 26, 2019
Multi-centre technical evaluation of the radiation-induced lymphocyte apoptosis assay as a predictive test for radiotherapy toxicityChristopher J Talbot, Marlon R Veldwijk, David Azria, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 29, 2021
ESTRO-ACROP recommendations on the clinical implementation of hybrid MR-linac systems in radiation oncologyStefanie Corradini, Filippo Alongi, Nicolaus Andratschke, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 22, 2023
A prospective registry study of stereotactic magnetic resonance guided radiotherapy (MRgRT) for primary liver tumorsKarl Bordeau, Morgan Michalet, Valérie Dorion, et al.Pageof 30